newsfilter
← Latest News
PR Newswire·

BioMarin Reports First Quarter 2026 Financial and Operating Results

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) today announced financial results for the first quarter ended March 31, 2026. "With the acquisition of...